IL-18 serves as a main effector of CAF-derived METTL3 against immunosuppression of NSCLC via driving NF-κB pathway
Article in Epigenetics (October 2023)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Article in Epigenetics (October 2023)
Article in Exploration of Immunology (January 2023)
Article in Anticancer Research (October 2022)